首页> 外文期刊>Acta ophthalmologica Scandinavica >Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration
【24h】

Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration

机译:Verteporfin治疗与玻璃体内曲安奈德联合治疗新生血管性年龄相关性黄斑变性后的时程和视网膜形态特征

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To identify characteristic morphological changes of the retina over time and the association with visual function after combined photodynamic therapy (PDT) and intravitreal triamcinolone (IVTA). Methods: In this retrospective study, 40 patients (40 eyes) were treated with PDT and same-day IVTA. Optical coherence tomography (OCT), fluorescein angiography (FA) and evaluation of distance visual acuity (VA) were performed. The anatomical changes within intra- and subretinal compartments and their detailed analysis and grading were the main outcome measures. Results: Intraretinal fluid (IRF) and subretinal fluid (SRF) by OCT decreased until 3 months (p < 0.01). At month 3, intraretinal cystoid spaces (ICS) had resolved or decreased in 84% of eyes, SRF in 58% and pigment epithelial detachment (FED) in 50%. Mean best-corrected VA (BCVA) improved significantly at month 1 (p < 0.01). Mean central retinal thickness (CRT) increased from 334 mum at baseline to 439 mum at day 1 (p = 0.03) before decreasing to 286 mum at day 7 (p = 0.06), 233 mum at month 1 (p = 0.001) and 255 mum at month 3 (p = 0.001). Conclusion: Combined verteporfin/IVTA therapy induces distinct time-related effects on the retina within the different intra- and subretinal compartments.
机译:目的:确定光动力疗法(PDT)和玻璃体内曲安奈德(IVTA)联合使用后视网膜随时间变化的特征性形态变化以及与视觉功能的关系。方法:在这项回顾性研究中,对40例患者(40眼)进行了PDT和当日IVTA治疗。进行了光学相干断层扫描(OCT),荧光素血管造影(FA)和远视力评估(VA)。主要的结果指标是视网膜内和视网膜下腔室内的解剖变化及其详细的分析和分级。结果:OCT的视网膜内液(IRF)和视网膜下液(SRF)减少至3个月(p <0.01)。在第3个月,视网膜内囊样间隙(ICS)在84%的眼中已消除或减少,SRF在58%的眼中或色素上皮脱离(FED)在50%的眼中。在第1个月,平均最佳矫正视力(BCVA)显着改善(p <0.01)。平均中央视网膜厚度(CRT)从基线的334微米增加到第1天的439微米(p = 0.03),然后在第7天降低到286微米(p = 0.06),在第1个月增加233 mp(p = 0.001)和255第三个月的妈妈(p = 0.001)。结论:韦替泊芬/ IVTA联合治疗对不同的视网膜内和视网膜下隔室内的视网膜具有明显的时间相关作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号